[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100532748":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":20,"responsibleParty":37,"collaborators":7,"id":40,"slug":41,"hasResults":42,"nctId":43,"briefTitle":44,"officialTitle":45,"acronym":46,"eligibilityCriteria":47,"healthyVolunteers":42,"sex":48,"minAge":49,"maxAge":7,"enrollmentInfo":50,"targetDuration":53,"studyType":54,"phases":7,"briefSummary":55,"conditions":56,"keywords":7,"overallStatus":23,"whyStopped":7,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":67},{"fullName":5,"class":6},"Shenyang Northern Hospital","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Yaling Han, MD","The General Hospital of Northern Theater Command","PRINCIPAL_INVESTIGATOR",[14,19],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Yi Li, MD","CONTACT","+86-24-28897309","doctorliyi@126.com",{"name":10,"role":16,"phone":7,"phoneExt":7,"email":7},[21],{"facility":22,"status":23,"city":24,"state":25,"zip":26,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"General Hospital of Northern Theater Command","RECRUITING","Shenyang","Liaoning","110016","China","CN",{"type":30,"coordinates":31},"Point",[32,33],123.43278,41.79222,{"lat":33,"lon":32},[36],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},{"type":12,"investigatorFullName":38,"investigatorTitle":39,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Han Yaling","Prof.","100532748","clinical-outcomes-of-patients-with-coronary-artery-disease-100532748",false,"NCT06216847","Clinical Outcomes of Patients With Coronary Artery Disease","Clinical Outcomes of Patients With Coronary Artery Disease Cohort Study","COCAD","Inclusion Criteria:\n\n* Age ≥ 18 years old\n* Hospitalization due to either confirmed or suspected CHD combined with one of the following features: previous PCI or CABG; previous myocardial infarction; previous coronary angiography revealing ≥ 50% stenosis in major coronary vessels; presentation with chest pain and pre-test probability of CHD \\> 65%; laboratory tests revealing objective evidence of myocardial ischemia; coronary CT angiography (CTA) showed ≥ 30% stenosis in major coronary vessels\n* Subjects undergoing at least one coronary imaging and one functional examination. Imaging examinations include coronary CTA, intravascular ultrasound (IVUS), or optical coherence tomography (OCT). Functional examination include fraction flow reservation (FFR), CT-FFR or quantitative flow ratio (QFR).\n* Written informed consent provided.\n\nExclusion Criteria:\n\n* History of mental illness, drug or alcohol abuse, or being unable to cooperate with follow-up visits for any reason;\n* Life expectancy \\\u003C1 year\n* Pregnant or plan to be pregnant within 1 year\n* Subjects participating in any other clinical trial\n* Other conditions deemed unsuitable for inclusion by the investigator","ALL","18 Years",{"count":51,"type":52},10000,"ESTIMATED","5 Years","OBSERVATIONAL","Coronary heart disease (CHD) stands as a foremost contributor to global mortality, characterized by complex pathogenesis that renders conventional \"one-size-fits-all\" preventive strategies inefficient. Therefore, the investigators designed a prospective, multi-center cohort study among patients hospitalized due to either confirmed or suspected CHD, which aimed to establish a holographic data set for the diagnosis and treatment of CHD and explore the impact of critical therapeutic strategies in the real world on the clinical outcomes of CHD patients, providing evidence to optimize the management pathway.",[57],"Coronary Heart Disease (CHD)","2025-09-03",{"date":60,"type":61},"2025-09-10","ACTUAL",{"date":63,"type":61},"2024-02-21",{"date":65,"type":52},"2030-10-31",{"name":5,"class":6},1]